Terminated PHASE4 INTERVENTIONAL NCT00042549

Lithotripsy for the Treatment of Gallstones

Biliary Lithotripsy in Combination With Actigall Versus Actigall Monotherapy for the Treatment of Symptomatic Cholesterol Gallstones

Sponsor: Medstone International

Conditions Cholelithiasis

Interventions Extracorporeal Shock Wave Lithotripsy ursodiol

Updated 6 times since 2017 Last updated: Jun 23, 2005 Started: May 31, 2002

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

This trial was terminated. No reason was provided.

This PHASE4 trial investigates Cholelithiasis and is currently terminated or withdrawn. Medstone International leads this study, which shows 6 recorded versions since 2002 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Jan 2026 — Present [monthly]

Terminated PHASE4
Sep 2024 — Present [monthly]

Terminated PHASE4
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE4
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE4
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Terminated PHASE4

First recorded

May 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Medstone International

Data source: Medstone International

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Houston, United States
• Richmond, United States